We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+7.31%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$1.02B
AUM Growth
+$269M
Cap. Flow
+$233M
Cap. Flow %
22.87%
Top 10 Hldgs %
44.41%
Holding
92
New
31
Increased
16
Reduced
12
Closed
24

Top Buys

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$36.6M
2
BABA icon
Alibaba
BABA
+$25.9M
3
ZBRA icon
Zebra Technologies
ZBRA
+$24.4M
4
ARMK icon
Aramark
ARMK
+$21.1M
5
COTY icon
Coty
COTY
+$20.3M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$24M
2
SGI
Somnigroup International
SGI
+$20.4M
3
KEYS icon
Keysight
KEYS
+$20.2M
4
RCL icon
Royal Caribbean
RCL
+$17.4M
5
RH icon
RH
RH
+$16.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.18%
2 Industrials 11.95%
3 Technology 10.39%
4 Consumer Discretionary 9.94%
5 Materials 6.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADPT icon
51
Adaptive Biotechnologies
ADPT
$3.68B
$5.55M 0.55%
+115,000
New +$5.09M
GEG icon
52
Great Elm Group
GEG
$74M
$5.45M 0.54%
1,267,030
– –
IQV icon
53
IQVIA
IQV
$38.4B
$4.53M 0.44%
28,121
-75,647
-73% -$10.6M
ARRY
54
DELISTED
Array Biopharma Inc
ARRY
$4.46M 0.44%
+96,380
New +$2.71M
TVRD
55
Tvardi Therapeutics
TVRD
$19M
$4.31M 0.42%
+5,569
New +$3.91M
MTEM
56
DELISTED
Molecular Templates, Inc.
MTEM
$4.31M 0.42%
34,386
+104
+0.3% +$11.3K
TMQ
57
Trilogy Metals
TMQ
$553M
$2.96M 0.29%
1,004,135
– –
SLGL icon
58
Sol-Gel Technologies
SLGL
$268M
$2.83M 0.28%
31,059
+7,064
+29% +$564K
GNCA
59
DELISTED
Genocea Biosciences, Inc.
GNCA
$2.61M 0.26%
+666,222
New +$3.48M
DCPH
60
PUT
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$2.25M 0.22%
+100,000
New +$2.34M
MITO
61
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$2.23M 0.22%
178,453
– –
XAIR icon
62
Beyond Air
XAIR
$4.56M
$2.23M 0.22%
+1,002
New +$2.13M
METC icon
63
Ramaco Resources Class A
METC
$581M
$1.47M 0.14%
285,525
– –
XLP icon
64
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.8B
$569K 0.06%
9,800
– –
DELL icon
65
Dell
DELL
$277B
$378K 0.04%
14,691
+781
+6% +$24.4K
DEST
66
DELISTED
Destination Maternity Corporation
DEST
$231K 0.02%
174,816
– –
MRNA icon
67
PUT
Moderna
MRNA
$22B
$157K 0.02%
+10,700
New +$230K
AMLP icon
68
Alerian MLP ETF
AMLP
$13B
– –
-162,712
Closed -$8.16M
ASH icon
69
Ashland
ASH
$3.29B
– –
-113,025
Closed -$8.83M
CCJ icon
70
Cameco
CCJ
$39.1B
– –
-822,683
Closed -$9.7M
DOCU
71
DocuSign
DOCU
$10.5B
– –
-84,864
Closed -$4.4M
EW icon
72
PUT
Edwards Lifesciences
EW
$51.1B
– –
-150,000
Closed -$9.57M
KYNB
73
PUT
Kyntra Bio
KYNB
$27.4M
– –
-4,000
Closed -$5.43M
HRTX icon
74
CALL
Heron Therapeutics
HRTX
$96.8M
– –
-150,000
Closed -$3.67M
IFRX icon
75
InflaRx
IFRX
$258M
– –
-175,414
Closed -$6.63M
1 2
3
4

Similar funds

GC
Greenvale Capital London, United Kingdom $912M AUM 34.2% 1-Year Est. Return
ICP
Ironvine Capital Partners Omaha, Nebraska $910M AUM 10.64% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
SAA
Southeast Asset Advisors Thomasville, Georgia $913M AUM 25.32% 1-Year Est. Return
GIG
Goodnow Investment Group Darien, Connecticut $913M AUM 11.84% 1-Year Est. Return
SI
Symmetry Investments St Helier, Jersey $913M AUM 30.59% 1-Year Est. Return
PAMI
Perseverance Asset Management International George Town, Cayman Islands $909M AUM 17.42% 1-Year Est. Return
BDP
Brehaut David Pascal $908M AUM

Kingdon Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Kingdon Capital Management held 92 positions worth $1.02B, up 36% from $748M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Kingdon Capital Management deployed $233M of net new capital in Q2 2019, opening 31 new positions and adding to 16 existing holdings. Its largest new stake was Freeport-McMoran: 3,140,882 shares worth $36.5M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Royal Caribbean, an estimated $17.4M trimmed.

  • Kingdon Capital Management's largest Q2 2019 buy was Freeport-McMoran: 3,140,882 shares worth $36.5M.
  • Kingdon Capital Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2019, an estimated $8.86M increase.
  • Kingdon Capital Management's biggest Q2 2019 reduction was Royal Caribbean, cutting an estimated $17.4M.
  • Kingdon Capital Management fully exited Celgene Corp in Q2 2019, selling an estimated $24M.
  • Kingdon Capital Management's ten largest holdings make up 44% of its $1.02B portfolio in Q2 2019.
  • Kingdon Capital Management opened 31 new positions and closed 24 in Q2 2019.
  • Kingdon Capital Management's portfolio value rose 36% quarter-over-quarter to $1.02B.

Based on Kingdon Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.